Safer chemotherapy? Race Oncology’s new drug heads to trials
Race Oncology Ltd is advancing the development of a reformulated chemotherapy drug aimed at reducing severe side effects, particularly cardiac-related risks, while preserving or improving efficacy. In this episode of After Market with Jonathan Jackson, CEO and managing director Daniel Tillett highlighted the drug’s potential to work alongside anthracyclines, a common class of chemotherapy agents, to enhance patient safety and treatment outcomes. The company is preparing for clinical trials to evaluate the drug’s performance in human subjects.
--------
25:41
The state of drug development in Australia: a case study
Amplia Therapeutics Ltd CEO and managing director Dr Chris Burns has had a long career in drug development, including discovering only the second Australian drug to receive US FDA approval. He has plenty of advice to share for Australian-based researchers and domestically developed biotech assets. Proactive's Susanna Nelson chats to him about the current state of clinical research and commercial drug development in Australia.
--------
28:47
Australian Vanadium reinforces potential for long-lasting, high-grade vanadium and battery metal project
Australian Vanadium Ltd (ASX:AVL) CEO Graham Arvidson sits down with Proactive’s Jonathan Jackson to discuss progress in the company's metallurgical testing following a recent merger with Technology Metals Australia Ltd (TMT). AVL plans to capitalise on the battery metal boom with its vanadium and high-grade iron project, leveraging its subsidiary VSUN to build out the Vanadium Flow Battery market and other future tech applications.
--------
18:30
Carbon capture and storage: An essential part of the circular economy
How can resource companies mitigate their carbon emissions in innovative ways? Proactive’s Phoebe Shields talks to CSIRO’s Dr Dia Milani, who leads the organisation’s CO2 utilisation team within the Sustainable Carbon Technologies group, about the urgency of including carbon capture and storage methods in the mix of tools to combat climate change – and the opportunities that abound for companies to apply the technology in Australia.
--------
15:44
Artemis Resources is chasing gold, copper and lithium in the Pilbara
Artemis Resources Ltd executive director George Ventouras talks to Proactive’s Susanna Nelson about the company’s projects, mostly in the West Pilbara, where it is exploring for gold, copper and lithium. George also weighs in on ‘the white gold boom’, the importance of a diverse and sustainable mining industry to the Australian economy and the future of mining in this country.
Welcome to After Market, the podcast from Proactive Australia with its finger firmly on the investor pulse.
Each month we take a closer look at the issues shaping and shifting the markets - from cost of living to climate, geopolitics to geology, macroeconomics to medtech and big data to battery metals.
Please note that the views of our interviewees are not the views of Proactive Investors. Seek independent investment advice before making any financial decisions and remember that nothing you hear on this pod constitutes investment advice.
Canada - english